Amgen AMGN
NASDAQ AMGN
$460.42 +0.14 (+0.03%)
At close: Nov 6, 2026 · 4:00 PM EST

Amgen (AMGN) Net Short-Term Debt Issued (Repaid) (2011 - 2017)

Updated

Amgen (AMGN) reported Current Debt of $540 million for Q3 2017.

Analysis

Amgen (AMGN) Net Short-Term Debt Issued (Repaid) (2011 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -4.36 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -682.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -24.00 Mn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 540.00 Mn
Dec 31, 2011 462.00 Mn
API Access

Amgen Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY